Introduction/Overview Histamine, a biogenic amine synthesized from the amino acid L-histidine, functions as a critical mediator in physiological and pathological processes, including the regulation of gastric acid secretion, neurotransmission in the central nervous system, and the inflammatory response. The pharmacology of antihistamines centers on the antagonism of histamine receptors, predominantly the H1 subtype, to mitigate … Read more

1. Introduction/Overview Prostaglandins and eicosanoids constitute a vast family of lipid-derived autacoids and paracrine hormones that exert profound and diverse physiological and pathophysiological effects. These compounds are not stored within cells but are synthesized de novo from membrane phospholipid-derived arachidonic acid in response to various mechanical, chemical, and hormonal stimuli. Their actions are typically local, … Read more

Introduction/Overview Histamine, a biogenic amine synthesized from the amino acid L-histidine, functions as a critical mediator in physiological and pathological processes. Its actions are primarily mediated through four distinct G-protein-coupled receptor subtypes: H1, H2, H3, and H4. Antihistamines, more precisely termed histamine receptor antagonists, are pharmacological agents that competitively inhibit the binding of histamine to … Read more

Introduction/Overview Gout represents a common and complex form of inflammatory arthritis characterized by the deposition of monosodium urate crystals in joints and other tissues, resulting from chronic hyperuricemia. The condition manifests through acute, intensely painful attacks, chronic arthropathy, and the potential development of tophi. The pharmacological management of gout is multifaceted, targeting both the acute … Read more

Introduction/Overview Gout is a common inflammatory arthritis characterized by the deposition of monosodium urate crystals in joints and other tissues, resulting from chronic hyperuricemia. The condition manifests as recurrent, intensely painful acute attacks and, if untreated, can progress to chronic tophaceous gout with joint destruction and renal impairment. The pharmacological management of gout is a … Read more

1. Introduction/Overview Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder characterized by persistent synovial inflammation, progressive joint destruction, and significant functional disability. The pharmacological management of RA has been fundamentally transformed by the development and clinical implementation of Disease-Modifying Antirheumatic Drugs (DMARDs). These agents are distinguished from purely symptomatic treatments, such as nonsteroidal anti-inflammatory … Read more

1. Introduction/Overview The management of rheumatoid arthritis (RA) and related autoimmune inflammatory arthropathies represents a cornerstone of clinical rheumatology and pharmacotherapy. Disease-modifying antirheumatic drugs (DMARDs) constitute the primary pharmacological intervention aimed not merely at symptom palliation but at altering the underlying disease course. The introduction of these agents has fundamentally transformed RA from a condition … Read more

Introduction/Overview Hematopoietic growth factors (HGFs) are a class of endogenous glycoproteins and their recombinant analogs that regulate the proliferation, differentiation, and functional activity of blood cell lineages. The clinical development and application of recombinant HGFs represent a pivotal advancement in supportive oncology and the management of various cytopenias. These agents have transformed patient care by … Read more